S 1573
An Act relative to newborn screenings for congenital cytomegalovirus
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This bill proposes to expand newborn screenings in Massachusetts to include testing for congenital cytomegalovirus (CMV). CMV is a common virus that can cause serious health problems in newborns if left untreated. By adding CMV screening, healthcare providers can identify infected infants early, allowing for timely intervention and potentially preventing long-term complications.
Key provisions
- Expand newborn screening to include testing for congenital cytomegalovirus (CMV).
- Require healthcare providers to notify parents of positive CMV screening results.
- Establish guidelines for managing infants diagnosed with CMV infection.
- Support research into the prevention and treatment of CMV.
- Ensure adequate funding for CMV screening programs.
Who is affected
- Newborn infants
- Parents of newborns
- Healthcare providers
- Public health officials
- Massachusetts residents
Notable changes
- Adds CMV screening to the existing newborn screening panel.
- May require changes to clinical management protocols for CMV-positive infants.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joan B. Lovely
Cosponsors
Adrian C. Madaro
Bradley H. Jones Jr.
Brian W. Murray
Bruce E. Tarr
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill S.1573 194th (Current)
An Act relative to newborn screenings for congenital cytomegalovirus
By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1573) of Joan B. Lovely, Jason M. Lewis, Paul K. Frost, Ryan C. Fattman and other members of the General Court for legislation relative to newborn screenings for congenital cytomegalovirus. Public Health.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Joan B. Lovely Status: Referred to Senate Committee on Ways and Means
Tabs
Bill History Petitioners Committee Vote Fiscal Note Primary Sponsor Summary
Bill History
Displaying 8 actions for Bill S.1573
| Date | Branch | Action |
| 2/27/2025 | Senate | Referred to the committee on Public Health |
| 2/27/2025 | House | House concurred |
| 7/3/2025 | Joint | Hearing scheduled for 07/14/2025 from 01:00 PM-05:00 PM in A-1 |
| 7/14/2025 | Joint | Hearing rescheduled to 07/14/2025 from 01:00 PM-06:45 PM in A-1 and Virtual Hearing updated to New End Time |
| 7/14/2025 | Joint | Hearing rescheduled to 07/14/2025 from 01:00 PM-06:05 PM in A-1 and Virtual Hearing updated to New End Time |
| 1/8/2026 | Senate | Accompanied by S1530 and S1552 |
| 1/8/2026 | Senate | Bill reported favorably by committee and referred to the committee on Health Care Financing |
| 3/12/2026 | Senate | Committee recommended ought to pass and referred to the committee on Senate Ways and Means |
Similar Bills
S.1405 193rd (2023 - 2024)
An Act relative to newborn screenings for congenital cytomegalovirus
S.1530 194th (Current)
An Act improving newborn screening tests
S.1366 193rd (2023 - 2024)
An Act improving newborn screening tests
H.2495 194th (Current)
An Act relative to LSDs (Lysosomal Storage Disorders) in infants
H.2430 194th (Current)
An Act including Krabbe Disease in newborn screening
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.